Global Nano Biotechnology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR122414271

Publication Date:

December 30, 2024

Pages:

102

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

IT & eHealth [2]

Pharma & Healthcare [3]

Description:

According to our latest research, the global Nano Biotechnology market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.
The Nano Biotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nano Biotechnology market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0-10 nm
10-100 nm
Market segment by Application, can be divided into
Pharmaceuticals
Medical Devices
Medical Research
Other
Market segment by players, this report covers
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Nano Biotechnology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nano Biotechnology, with recent developments and future plans
Chapter 3, the Nano Biotechnology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Nano Biotechnology market forecast, by regions, with revenue, from 2024 to 2030.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.
Chapter 7 and 8, to describe Nano Biotechnology research findings and conclusion, appendix and data source.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Nano Biotechnology
1.2 Classification of Nano Biotechnology by Type
1.2.1 Overview: Global Nano Biotechnology Market Size by Type: 2024 Versus 2030
1.2.2 Global Nano Biotechnology Revenue Market Share by Type in 2030
1.2.3 0-10 nm
1.2.4 10-100 nm
1.3 Global Nano Biotechnology Market by Application
1.3.1 Overview: Global Nano Biotechnology Market Size by Application: 2024 Versus 2030
1.3.2 Pharmaceuticals
1.3.3 Medical Devices
1.3.4 Medical Research
1.3.5 Other
1.4 Global Nano Biotechnology Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Nano Biotechnology Market Drivers
1.5.2 Nano Biotechnology Market Restraints
1.5.3 Nano Biotechnology Trends Analysis
2 Company Profiles
2.1 Aduro BioTech
2.1.1 Aduro BioTech Details
2.1.2 Aduro BioTech Major Business
2.1.3 Aduro BioTech Nano Biotechnology Product and Solutions
2.1.4 Aduro BioTech Recent Developments and Future Plans
2.2 Calando Pharmaceuticals
2.2.1 Calando Pharmaceuticals Details
2.2.2 Calando Pharmaceuticals Major Business
2.2.3 Calando Pharmaceuticals Nano Biotechnology Product and Solutions
2.2.4 Calando Pharmaceuticals Recent Developments and Future Plans
2.3 Biosante Phosphate Pharmaceuticals
2.3.1 Biosante Phosphate Pharmaceuticals Details
2.3.2 Biosante Phosphate Pharmaceuticals Major Business
2.3.3 Biosante Phosphate Pharmaceuticals Nano Biotechnology Product and Solutions
2.3.4 Biosante Phosphate Pharmaceuticals Recent Developments and Future Plans
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Nano Biotechnology Product and Solutions
2.4.4 Celgene Corporation Recent Developments and Future Plans
2.5 Elan Pharmaceuticals
2.5.1 Elan Pharmaceuticals Details
2.5.2 Elan Pharmaceuticals Major Business
2.5.3 Elan Pharmaceuticals Nano Biotechnology Product and Solutions
2.5.4 Elan Pharmaceuticals Recent Developments and Future Plans
2.6 Flamel Technologies
2.6.1 Flamel Technologies Details
2.6.2 Flamel Technologies Major Business
2.6.3 Flamel Technologies Nano Biotechnology Product and Solutions
2.6.4 Flamel Technologies Recent Developments and Future Plans
2.7 Nanophase Technologies
2.7.1 Nanophase Technologies Details
2.7.2 Nanophase Technologies Major Business
2.7.3 Nanophase Technologies Nano Biotechnology Product and Solutions
2.7.4 Nanophase Technologies Recent Developments and Future Plans
2.8 Sigma Aldrich Company
2.8.1 Sigma Aldrich Company Details
2.8.2 Sigma Aldrich Company Major Business
2.8.3 Sigma Aldrich Company Nano Biotechnology Product and Solutions
2.8.4 Sigma Aldrich Company Recent Developments and Future Plans
2.9 Dendritic Nanotechnologies
2.9.1 Dendritic Nanotechnologies Details
2.9.2 Dendritic Nanotechnologies Major Business
2.9.3 Dendritic Nanotechnologies Nano Biotechnology Product and Solutions
2.9.4 Dendritic Nanotechnologies Recent Developments and Future Plans
2.10 SkyePharma Pharmaceuticals
2.10.1 SkyePharma Pharmaceuticals Details
2.10.2 SkyePharma Pharmaceuticals Major Business
2.10.3 SkyePharma Pharmaceuticals Nano Biotechnology Product and Solutions
2.10.4 SkyePharma Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nano Biotechnology Revenue and Share by Players (2024 & 2030)
3.2 Nano Biotechnology Players Head Office, Products and Services Provided
3.3 Nano Biotechnology Mergers & Acquisitions
3.4 Nano Biotechnology New Entrants and Expansion Plans
4 Global Nano Biotechnology Forecast by Region
4.1 Global Nano Biotechnology Market Size by Region: 2024 VS 2030
4.2 Global Nano Biotechnology Market Size by Region, (2024-2030)
4.3 North America
4.3.1 Key Companies of Nano Biotechnology in North America
4.3.2 Current Situation and Forecast of Nano Biotechnology in North America
4.3.3 North America Nano Biotechnology Market Size and Prospect (2024-2030)
4.4 Europe
4.4.1 Key Companies of Nano Biotechnology in Europe
4.4.2 Current Situation and Forecast of Nano Biotechnology in Europe
4.4.3 Europe Nano Biotechnology Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
4.5.1 Key Companies of Nano Biotechnology in Asia-Pacific
4.5.2 Current Situation and Forecast of Nano Biotechnology in Asia-Pacific
4.5.3 Asia-Pacific Nano Biotechnology Market Size and Prospect (2024-2030)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Nano Biotechnology in South America
4.6.2 Current Situation and Forecast of Nano Biotechnology in South America
4.6.3 South America Nano Biotechnology Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
4.7.1 Key Companies of Nano Biotechnology in Middle East & Africa
4.7.2 Current Situation and Forecast of Nano Biotechnology in Middle East & Africa
4.7.3 Middle East & Africa Nano Biotechnology Market Size and Prospect (2024-2030)
5 Market Size Segment by Type
5.1 Global Nano Biotechnology Market Forecast by Type (2024-2030)
5.2 Global Nano Biotechnology Market Share Forecast by Type (2024-2030)
6 Market Size Segment by Application
6.1 Global Nano Biotechnology Market Forecast by Application (2024-2030)
6.2 Global Nano Biotechnology Market Share Forecast by Application (2024-2030)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

Companies Mentioned:

Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂